Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.37 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | EPOR | P19235 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7245309 | 1.00 | OPRD1 (0.39) | OPRD1OPRK1AOC3C5AR1ALDH1A1 | |
| SCHEMBL7037077 | 0.93 | OPRD1 (0.37) | OPRD1OPRK1ALDH1A1 | |
| SCHEMBL28019387 | 0.90 | ALDH1A1 (0.41) | AOC3ALDH1A1ABCB1TSHRNPC1 | |
| SCHEMBL719264 | 0.90 | ALDH1A1 (0.41) | AOC3ALDH1A1ABCB1TSHRNPC1 | |
| SCHEMBL719263 | 0.90 | ALDH1A1 (0.41) | AOC3ALDH1A1ABCB1TSHRNPC1 | |
| SCHEMBL7686556 | 0.88 | OPRD1 (0.37) | OPRD1OPRK1C5AR1ALDH1A1POLB | |
| SCHEMBL6493560 | 0.87 | ADAMTS4 (0.37) | OPRD1OPRK1EPORLTA4H | |
| SCHEMBL6493557 | 0.87 | ADAMTS4 (0.37) | OPRD1OPRK1EPORLTA4H | |
| SCHEMBL7688304 | 0.87 | PDGFRA (0.37) | — | |
| SCHEMBL7688302 | 0.87 | PDGFRA (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | XDH, ADH1A, ADRB1 | OPRD1 14/4885OPRK1 36/4885AOC3 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.